Hypertonic saline reduces intracranial hypertension in the presence of high serum and cerebrospinal fluid osmolalities

Neurocritical Care

Volumn 17, Issue 2, 2012, Pages 204-210

  Paredes Andrade, Eduardo ^a   Solid, Craig A ^b   Rockswold, Sarah B ^a,c   Odland, Rick M ^a,c   Rockswold, Gaylan L ^a,c  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cerebrospinal fluid osmolality; Hypertonic saline; Intracranial pressure; Osmotherapy; Serum osmolality; Traumatic brain injury

Indexed keywords

CREATININE; NITROGEN; OSMOTIC AGENT; SODIUM; SODIUM CHLORIDE; UREA;

ADULT; AGED; BRAIN PERFUSION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPEROSMOLALITY; INTRACRANIAL HYPERTENSION; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; TRAUMATIC BRAIN INJURY; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BRAIN INJURIES; CEREBROSPINAL FLUID; FEMALE; FLUID THERAPY; HUMANS; INTRACRANIAL HYPERTENSION; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; RETROSPECTIVE STUDIES; SALINE SOLUTION, HYPERTONIC; SERUM; SODIUM;

EID: 84867774132     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-011-9574-z     Document Type: Review

References (36)

1. Bhardwaj A. Osmotherapy in neurocritical care. Curr Neurol Neurosci Rep. 2007;7(6):513-21. (Pubitemid 350090310)
2. Weed LH, McKibben PS. Experimental alteration of brain bulk. Am J Physiol. 1919;48(4):531-58.
3. Hesdorffer DC, Ghajar J. Marked improvement in adherence to traumatic brain injury guidelines in United States trauma centers. J Trauma. 2007;63(4):841-8.
4. Wenham TN, Hormis AP, Andrzejowski JC. Hypertonic saline after traumatic brain injury in UK neuro-critical care practice. Anaesthesia. 2008;63(5):558-9. (Pubitemid 351533366)
5. Battison C, Andrews PJD, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med. 2005;33(1):196-202. (Pubitemid 40116557)
6. Harutjunyan L, Holz C, Rieger A, Menzel M, Grond S, Soukup J. Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients - a randomized clinical trial. Crit Care. 2005;9(5):R530-40.
7. Kerwin AJ, Schinco MA, Tepas JJ, Renfro WH, Vitarbo EA, Muehlberger M. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury - a pilot study. J Trauma. 2009; 67(2):277-82.
8. Rockswold GL, Solid CA, Paredes-Andrade E, Rockswold SB, Jancik JT, Quickel RR. Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen. Neurosurgery. 2009;65(6):1035-42.
9. Vialet R, Albanese J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% is more effective than 2 mL/kg 20% mannitol. Crit Care Med. 2003;31(6):1683-7. (Pubitemid 36714221)
10. Ware ML, Nemani VM, Meeker M, Lee C, Morabito DJ, Manley DT. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery. 2005;57(4):727-36.
11. Paczynski RP. Osmotherapy: basic concepts and controversies. Crit Care Clin. 1997;13(1):105-29. (Pubitemid 27044784)
12. Ziai WC, Toung TJK, Bhardwaj A. Hypertonic saline. First-line therapy for cerebral edema? J Neurol Sci. 2007;261(1-2):157-66. (Pubitemid 47313508)
13. Becker DP, Vries J. The alleviation of increased intracranial pressure by the chronic administration of osmotic agents. In: Brock M, Dietz H, editors. Intracranial pressure, experimental and clinical aspects. Berlin: Springer-Verlag; 1972. p. 309-15.
14. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitolinduced acute renal failure. Medicine. 1990;69(3):153-9.
15. Brain Trauma Foundation. Guidelines for the management of traumatic brain injury, third edition. J Neurotrauma. 2007; 24(Suppl 1):S1-106.
16. Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg. 1992;77(4): 584-9.
17. Khanna S, Davis D, Peterson B, et al. Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med. 2000;28(4):1144-51. (Pubitemid 30262092)
18. Peterson B, Khanna S, Fisher B, Marshall L. Prolonged hypernatremia controls elevated intracranial pressure in head injury pediatric patients. Crit Care Med. 2000;28(4):1136-43. (Pubitemid 30262091)
19. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9): 604-12.
20. Klatzo I. Neuropathological aspects of brain edema. J Neuropathol Exp Neurol. 1967;26(1):1-14.
21. Zornow MH. Hypertonic saline as a safe and efficacious treatment of intracranial hypertension. J Neurosurg Anesthesiol. 1996;8(2):175-7. (Pubitemid 26099796)
22. Fishman RA. Blood brain barrier. In: Fishman RA, editor. Cerebrospinal fluid in diseases of the nervous system. Philadelphia: WB Saunders; 1992. p. 43-69.
23. Fishman RA. Factors influencing the exchange of sodium between plasma and cerebrospinal fluid. J Clin Investig. 1959;38(10):1698-708.
24. Swanson PD. Neurological manifestations of hypernatremia. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology; vol 28(2): metabolic and deficiency diseases of the nervous system. Amsterdam: Elsevier/North Holland; 1976. pp. 443-61.
25. Johanson CE. Choroid plexus-cerebrospinal fluid circulatory dynamics: impact on brain growth, metabolism, and repair. In: Conn PM, editor. Neuroscience in medicine. 3rd ed. Beaverton: Humana Press; 2008. p. 173-200.
26. Strange K. Regulation of solute and water balance and cell volume in the central nervous system. J Am Soc Nephrol. 1992;3(1):12-27.
27. McManus ML, Churchwell KB, Strange K. Regulation of cell volume and health and disease. N Engl J Med. 1995;333(19): 1260-6.
28. Simma B, Burger R, Falk M, Sacher P, Fanconi S. A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer's solution versus hypertonic saline. Crit Care Med. 1998;26(7):1265-70. (Pubitemid 28334983)
29. Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med. 2000;28(9):3301-13.
30. Berger S, Härtl R. Traumatic brain injury and use of hypertonic solutions. Transfus Altern Transfus Med. 2005;6(4):59-68.
31. Horn P, Münch E, Vajkoczy P, et al. Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates. Neurol Res. 1999;21(8):758-64.
32. Palma L, Bruni G, Fiaschi AI, Mariottini A. Passage of mannitol into the brain around gliomas: a potential cause of rebound phenomenon. J Neurosurg Sci. 2006;50(3):63-6. (Pubitemid 44831670)
33. Sankar T, Assina R, Karis JP, Theodore N, Preul MC. Neurosurgical implications of mannitol accumulation within a meningioma and its peritumoral region demonstrate by magnetic resonance spectroscopy: case report. J Neurosurg. 2008;108(5): 1010-3. (Pubitemid 351656851)
34. Papangelou A, Lewin JJ III, Mirski MA, Stevens RD. Pharmacologic management of brain edema. Curr Treat Options Neurol. 2009;11(1):64-73.
35. Nau R, Desel H, Lassek C, et al. Slow elimination of mannitol from human cerebrospinal fluid. Eur J Clin Pharmacol. 1997; 53(3-4):271-4. (Pubitemid 28019061)
36. Polderman KH, van de Kraats G, Dixon JM, Vandertop WP, Girbes ARJ. Increases in spinal fluid osmolarity induced by mannitol. Crit Care Med. 2003;31(2):584-90. (Pubitemid 36232959)